China's Sinovac to crank up vaccine output for foreign demand

Pharma company is integral to Beijing's medical diplomacy

20200925N Sinovac

Sinovac built its new Beijing vaccine production site in just four months. © Reuters

SHIN WATANABE, Nikkei staff writer

BEIJING -- China's Sinovac Biotech is prepared to rapidly increase output of its coronavirus vaccine candidate in response to demand overseas, the head of the pharmaceutical maker said Thursday,

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.